Clinical Trial Update: Efficacy and Safety Study of Finafloxacin Used in Helicobacter Pylori Infected Patients [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of finafloxacin in patients with Helicobacter pylori infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspepsia
• Helicobacter Pylori Infection

Drugs mentioned

• Finafloxacin (finafloxacin)

Snippet

Sponsor: MerLion Pharmaceuticals GmbH | Conditions: Gram-Negative Bacterial Infections, Helicobacter Infections | Phase 2 | Status: COMPLETED